 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Contact:
Jacques Cornet, VP of Business Development & Strategic Marketing
Cedara Software Corp.
905.672.2100 x2564 jacques.cornet@cedara.com
|
|
Media Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
(414) 977-4254
bethfj@merge.com
|
|
Attention: Business/Financial Editors:
CEDARA SOFTWARE TO SHOWCASE INNOVATIVE TOOLS FOR HEALTHCARE IT PROVIDERS TO INTEGRATE IMAGE DATA WITH CLINICAL DIAGNOSTIC INFORMATION AT HIMSS CONFERENCE
- Cedara to introduce innovative new tools that provide integrators, IT consultants information solution providers and other OEM’s with tight integration between image data and multiple clinical information sources on a single desktop
- Cedara to support diagnostic visualization from any data source through web enabled solution, Cedara I-Reach™
- Innovative tools to include C4, a leading edge framework for integration of clinical imaging information into enterprise applications.
Toronto, ON, February 9, 2006 – Cedara Software, a Merge Healthcare company (Nasdaq: MRGE; TSX: MRG) and a leading independent developer of medical software technologies for the global healthcare market, today announced plans to showcase innovative tools for Healthcare IT Providers to help provide tight integration between image data and multiple clinical information sources on a single desktop, throughout a single enterprise, or from disparate sources across the globe at the 2006 Healthcare Information and Management Systems Society (HIMSS) Conference.
A major challenge for healthcare professionals is the need to access comprehensive patient information on a single workstation from isolated information systems. This includes medical images from PACS installations, data from other clinical areas such as cardiology and lab results, as well as enterprise information systems (HIS), which are often needed by medical practitioners to fully support diagnostic decision-making for a patient. Cedara’s portfolio of software tools are designed to help solve this challenge at multiple levels throughout the healthcare enterprise by displaying comprehensive patient data on any desktop; enabling integration of any information source in a medical facility; and help include diagnostic images and information into enterprise EMR solutions through multi site information access.
Part of this innovative new approach to workflow includes a new structure for managing advanced visualization. A common challenge experienced by practitioners working in clinical environments comes from time wasted moving between different applications (and workstations) to perform routine image analysis of different diagnostic data. Cedara’s new Clinical Control Center (C4), provides a means to tightly integrate clinical functionality into a single workstation. Through the use of configurable protocols, healthcare professionals can use C4 to automatically launch independent viewing applications from a single patient worklist. For OEM companies, this capability allows seamless integration of third party clinical plug-ins. While C4 provides functional integration for clinical plug-ins from any vendor, it will be demonstrated at HIMSS with a host of advanced visualization solutions from Cedara, including Cedara PET/CT™, Cedara IllumiView™, Cedara OrthoWorks™, Cedara I-Response™, Cedara PrimeLung™ and Cedara CalScore™.
Building on a wealth of experience in medical imaging, Cedara will also demonstrate a variety of tools designed to help organizations implement standards established by HIPAA, IHE, DICOM and HL7. Cedara’s innovative connectivity tools include an innovative image application development platform, Cedara OpenEyes™; C4™ Clinical Desktop; MergePort™, a DICOM and HL7 workflow broker; Cedara’s medical workflow engine; Cedara I-Reach™, a web enabled diagnostic workstation; and Cedara aXigate™, a clinical information system. These tools are uniquely designed to establish dynamic connections to any data source throughout the healthcare enterprise, either individually or in combination. Using leading edge architecture and built with XML, Java and AJAX interfaces, Cedara’s technology allows Healthcare IT professionals to leverage existing information systems through a middleware approach to information management.
“Cedara’s toolkit approach to integrating imaging data and clinical information significantly expands the value and availability of patient information,” said Brian Pedlar, President of Cedara Software. “Workflow, integration and information exchange represent an important piece of the solution for EMR, System Integrators and Process Management companies. Any Healthcare IT provider that wants to broaden imaging revenue opportunities within their customer base or is faced with the challenge of providing tight integration between image data and multiple clinical information sources on a single desktop will find these toolkits of value.”
Cedara Software, a leading independent developer of medical software technologies for the OEM marketplace, can be found at booth #7601 during HIMSS ’06 at the San Diego Convention Center.
###
Cedara Software is a Merge Healthcare company focused on the development of custom
engineered software applications and development tools for the medical imaging OEM and
International markets. Cedara software is deployed in hospitals and clinics worldwide and is
licensed by many of the world's leading medical device and healthcare information technology
companies. Cedara technologies and expertise span all the major digital imaging modalities
including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray,
mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron emission tomography (PET) and fluoroscopy. Cedara medical imaging offerings are used in all aspects of clinical imaging workflow including the capture of a patient's digital image; the archiving, communication and manipulation of digital images; sophisticated clinical applications to analyze digital images; and the use of imaging in minimally-invasive surgery. For additional information, visit our website at www.cedara.com.
Merge Healthcare is a market leader in the development and delivery of medical imaging and
information management software and services. With over twenty years of leadership in the
medical imaging and healthcare information technology markets, Merge Healthcare provides
innovative solutions for both OEM and the end-user healthcare markets. We custom engineer
clinical and imaging applications and development tools that are on the forefront of medicine and its use of medical imaging for OEM and international customers. We develop innovative medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
All trademarks appearing in this release are the property of Cedara Software Corp.
# # #
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
